OrbiMed’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q3
Sell
-536,000
Closed -$7.76M 133
2013
Q2
$7.76M Buy
+536,000
New +$7.76M 0.16% 77